Safety of Bioelectrical Impedance Analysis in Patients Equipped With Implantable Cardioverter Defibrillators

Meyer, Philippe; Makhlouf, A; Engkolo, Louis Paulin Mondouagne; Trentaz, F.; Thibault, Ronan; Pichard, Claude; Burri, Haran

doi:10.1177/0148607116633823

Cited by 18 publications

(7 citation statements)

References 12 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, since these arrhythmias occurred more than 30 minutes after the BIA measurement in patients with a recent history of arrhythmias, they were likely coincidental and not induced by BIA. Consistently, Meyer et al reported no evidence of artefacts from BIA in the intracardiac electrograms of their stable outpatient cohort 28 …”

Section: Discussionmentioning

confidence: 57%

“…Since the electrodes of the BIA device are placed on the hands and feet, this observation supports our findings. Moreover, BIA measurements have been rated as safe in small clinical study which found no evidence of interference with ICDs or CRT‐Ds and no change in ICD and CRT lead impedance during the measurement, even after setting the threshold to maximum sensitivity 28,33 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Safety of bioelectrical impedance analysis in advanced heart failure patients

Roehrich

Suendermann

Just

et al. 2020

Pacing Clinical Electrophis

View full text Add to dashboard Cite

Background: Cardiac cachexia and frailty are major complications of advanced heart failure (AHF). Bioelectrical impedance analysis (BIA) may provide valuable information regarding fluid balance, muscle mass and prognosis. The main concerns regarding the use of BIA in AHF patients remain arrhythmias and electromagnetic interferences with cardiac implantable electronic devices (CIEDs). Reliable data regarding patients on continuous-flow ventricular assist device (cf-VAD) remain scarce. The aim of this study is to evaluate the safety of BIA in AHF patients on pro-arrhythmogenic therapy with an implanted CIED and/or with a cf-VAD. Methods: We prospectively performed 217 BIA measurements in 143 AHF patients at risk of severe arrhythmias due to inotropic support/a history of ventricular arrhythmias and/or treated with CIED, including 104 patients with an ICD, CRT or pacemaker and 95 patients with a cf-VAD. All patients were under continuous Electrocardiogram (ECG) monitoring and clinical surveillance for 24 hours. Results: No adverse events were observed during the 217 BIA measurements: No rhythm disturbances were documented in the telemetric monitoring during or within 30 minutes after the measurement. CIEDs showed no malfunction, regardless of the location measured or the device manufacturer. In particular, no inappropriate shocks were observed. No alarms, flow disturbances, or malfunctions of the cf-VAD occurred during or after the measurements. Conclusion: We consider BIA a safe measurement with major clinical relevance in our cohort of AHF patients, despite an increased arrhythmic potential on inotropic support or the presence of implanted electronic devices (ICD, CRT, pacemaker and cf-VAD).

show abstract

Section: Discussionmentioning

confidence: 57%

Section: Discussionmentioning

confidence: 99%

Safety of bioelectrical impedance analysis in advanced heart failure patients

Roehrich

Suendermann

Just

et al. 2020

Pacing Clinical Electrophis

View full text Add to dashboard Cite

show abstract

“…In a recent study, 63 patients implanted with various single-chamber, dual-chamber and biventricular ICDs from different manufacturers underwent BIA measurements in concomitance with routine ICD controls [30]. The study revealed no electromagnetic interferences or artifacts during real-time electrocardiogram recordings using an electrical current of 0.8m Amp at frequencies from 5-100 kHz.…”

Section: Table 1: Patient Characteristicsmentioning

confidence: 91%

Bioimpedance analysis is safe in patients with implanted cardiac electronic devices

et al. 2019

View full text Add to dashboard Cite

“…Bioimpedance spectroscopy is typically not performed on individuals with amputations and implanted metallic devices, although it can be safely performed for patients with ICDs. 23 Lung ultrasound is performed by the clinician using a linear or phased-array probe to detect the presence of B-lines. The presence of many B-lines increases the likelihood that a patient is above their dry weight.…”

Section: Returning To the Casementioning

confidence: 99%

Thinking Volume First: Developing a Multifaceted Systematic Approach to Volume Management in Hemodialysis

Blum

Beaubien‐Souligny

Silver

et al. 2019

Can J Kidney Health Dis

View full text Add to dashboard Cite

Purpose of review: Volume overload and hypovolemia-induced symptoms are common in the hemodialysis (HD) population and frequently result in emergency department visits and hospitalization. A structured strategy for the reporting, evaluation, and management of disordered volume status may improve clinical outcomes and the patient experience. We developed a new strategy that systematically addresses volume issues by leveraging the electronic medical record, technological adjuncts, and multidisciplinary expertise to institute new processes of care in our HD unit. Sources of information: This initiative was implemented in a unit located in an urban academic hospital where 250 patients receive maintenance HD. This initiative involved a multidisciplinary team of health professionals including physicians, nurse practitioners, social workers, and dieticians. Methods: We generated volume metrics for HD recipients based on routinely collected data from the unit’s electronic medical record. We then engaged stakeholders in a root cause analysis to identify the major causes of abnormal volume metrics locally. We subsequently developed interventions that were designed to address each of the major causes in a pragmatic and sustainable program. Key findings: The final product was a local volume management program with 3 components. First, we integrated volume metric reporting into the routine surveillance bloodwork reports across our unit. This enabled the clinical teams to more easily target patients at risk for volume-related adverse events and provide them with closer surveillance. Those identified with abnormal volume metrics were then evaluated with the use of technologic adjuncts such as lung ultrasound and bioimpedance spectroscopy to complement traditional assessments of volume status. Finally, those with abnormal volume metrics underwent rigorous interdisciplinary review for potential nutritional/social interventions. Limitations: While we report the successful initial implementation of the program within a single center, it remains unclear whether this initiative will lead to meaningful benefits for HD recipients, be readily applicable in other centers, or be sustainable in the long term. Implications: This volume management program will need further evaluation linked to outcome assessment and feasibility in other centers before wider adoption is advocated.

show abstract

Safety of Bioelectrical Impedance Analysis in Patients Equipped With Implantable Cardioverter Defibrillators

Abstract: BIA can be safely performed in patients equipped with ICDs without cardiac monitoring. Current guidelines should be updated accordingly.

Cited by 18 publications

References 12 publications

Safety of bioelectrical impedance analysis in advanced heart failure patients

Safety of bioelectrical impedance analysis in advanced heart failure patients

Bioimpedance analysis is safe in patients with implanted cardiac electronic devices

Thinking Volume First: Developing a Multifaceted Systematic Approach to Volume Management in Hemodialysis

Contact Info

Product

Resources

About